Acute Myeloblastic Leukemia Panel

11,000.00

The Acute Myeloblastic Leukemia Panel is a set of laboratory tests used to diagnose and classify Acute Myeloblastic Leukemia (AML), a fast-growing cancer affecting myeloid white blood cells. This panel typically includes a complete blood count (CBC) with differential, peripheral blood smear, bone marrow aspiration and biopsy, immunophenotyping (flow cytometry), cytogenetic analysis, and molecular genetic testing. These tests help identify abnormal myeloblasts and genetic mutations characteristic of AML.

Enquiry Here

    Description

    Why It’s Done:

    • To diagnose Acute Myeloblastic Leukemia in patients with symptoms such as fatigue, bruising, infections, or anemia.
    • To classify AML subtypes for appropriate treatment planning.
    • To detect genetic abnormalities that influence prognosis and guide targeted therapy.
    • To monitor response to treatment and detect relapse.
    • To assist in risk assessment and guide therapy choices.

    Preparation:

    • No special preparation is usually required for blood tests.
    • Bone marrow aspiration and biopsy may require fasting for several hours prior and avoiding certain medications, as directed by the healthcare provider.
    • Inform your healthcare provider about any medications, allergies, or medical conditions before testing.
    • Follow any specific instructions given for the bone marrow procedure.